-
-
-
-
-
-
-
bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
-
-
-
-
-
-
-
bioAffinity Technologies reports 146% jump in CyPath Lung test sales
-
-
-
-
-
-
-
bioAffinity Technologies receives US patent allowance for lung cancer test
-
-
-
-
-
-
-
bioAffinity Technologies receives China patent for lung cancer diagnostic
-
-
-
-
-
-
-
bioAffinity (BIAF) Reports Record $9.4M Revenue for 2024
-
-
-
-
-
-
-
bioAffinity (BIAF) Names J. Michael Edwards as Chief Financial Officer
-
-
-
481,533 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


